Privia Health Group, Inc. (PRVA)
- Previous Close
18.05 - Open
18.09 - Bid 18.76 x 300
- Ask 18.82 x 300
- Day's Range
17.85 - 19.02 - 52 Week Range
17.54 - 30.15 - Volume
837,664 - Avg. Volume
983,941 - Market Cap (intraday)
2.231B - Beta (5Y Monthly) 0.81
- PE Ratio (TTM)
98.95 - EPS (TTM)
0.19 - Earnings Date May 9, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
27.67
Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia.
www.priviahealth.com1,102
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: PRVA
Performance Overview: PRVA
Trailing total returns as of 4/23/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PRVA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PRVA
Valuation Measures
Market Cap
2.23B
Enterprise Value
1.85B
Trailing P/E
98.95
Forward P/E
75.19
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.41
Price/Book (mrq)
3.97
Enterprise Value/Revenue
1.12
Enterprise Value/EBITDA
68.04
Financial Highlights
Profitability and Income Statement
Profit Margin
1.39%
Return on Assets (ttm)
1.44%
Return on Equity (ttm)
3.73%
Revenue (ttm)
1.66B
Net Income Avi to Common (ttm)
23.08M
Diluted EPS (ttm)
0.19
Balance Sheet and Cash Flow
Total Cash (mrq)
389.51M
Total Debt/Equity (mrq)
1.37%
Levered Free Cash Flow (ttm)
71.75M
Research Analysis: PRVA
Company Insights: PRVA
Fair Value
Dividend Score
Hiring Score
Insider Sentiment Score
Research Reports: PRVA
PRVA: Lowering target price to $19.00
PRIVIA HEALTH GROUP INC has an Investment Rating of HOLD; a target price of $19.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Low; and a Value Subrating of High.
RatingPrice TargetPRVA: Raising target price to $20.00
PRIVIA HEALTH GROUP INC has an Investment Rating of HOLD; a target price of $20.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Low; and a Value Subrating of High.
RatingPrice TargetPRVA: Rating increased to a HOLD
PRIVIA HEALTH GROUP INC has an Investment Rating of HOLD; a target price of $14.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Low; and a Value Subrating of High.
RatingPrice TargetPRVA: Rating decreased to a SELL
PRIVIA HEALTH GROUP INC has an Investment Rating of SELL; a target price of $20.000000; an Industry Subrating of Low; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of High.
RatingPrice Target